2017 | Screening of breast cancer stem cell inhibitors using a protein kinase inhibitor library | 강덕희; 오억수; 최학선; 김달아; 정희성 | Article |
2017 | Selective tubular activation of hypoxia-inducible factor-2 alpha has dual effects on renal fibrosis | 강덕희; 최규복; 권기환; 김승정; 한기환; 류동열; 최윤희; 김민석 | Article |
2006 | Serum uric acid: A risk factor and a target for treatment? | 강덕희 | Conference Paper |
2005 | Subtle renal injury is likely a common mechanism for salt-sensitive essential hypertension | 강덕희 | Short Survey |
2014 | Syndecan-2 regulates melanin synthesis via protein kinase C βII-mediated tyrosinase activation | 강덕희; 오억수 | Article |
2009 | Systemic inflammation, metabolic syndrome and progressive renal disease | 강덕희 | Review |
2019 | Tannic acid attenuates the formation of cancer stem cells by inhibiting NF-kappa B-mediated phenotype transition of breast cancer cells | 강덕희; 오억수; 유은선; 최학선; 김달아 | Article |
2013 | Targeting syndecans: A promising strategy for the treatment of cancer | 강덕희; 오억수 | Review |
2016 | Technique failure in Korean incident peritoneal dialysis patients: a national population-based study | 한후재; 강덕희; 최규복; 김승정; 류동열 | Article |
2004 | TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways | 강덕희 | Article |
2017 | The additional benefit of weighted subjective global assessment (SGA) for the predictability of mortality in incident peritoneal dialysis patients: A prospective study | 강덕희; 최규복; 김승정; 류동열 | Article |
2009 | The association between fetal and postnatal growth status and serum levels of uric acid in children at 3 years of age | 하은희; 강덕희; 박은애; 김영주; 박혜숙; 이화영; 조수진; 박보현 | Article |
2019 | The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD | 강덕희 | Article |
2013 | The extracellular domain of syndecan-2 regulates the interaction of HCT116 human colon carcinoma cells with fibronectin | 강덕희; 오억수; 박성수 | Article |
2004 | The Impact of Gender on Progression of Renal Disease: Potential Role of Estrogen-Mediated Vascular Endothelial Growth Factor Regulation and Vascular Protection | 윤견일; 강덕희 | Article |
2003 | The impact of gender on progression of renal disease: Potential role of estrogen-mediated VEGF regulation and vascular protection. | 강덕희; 유은선 | Meeting Abstract |
2019 | The interactive effects of input and output on managing fluid balance in patients with acute kidney injury requiring continuous renal replacement therapy | 강덕희; 최규복; 김승정; 류동열; 이지은; 이신아; 오형중; 이혜아 | Article |
2016 | The relationship between magnesium and endothelial function in end-stage renal disease patients on hemodialysis | 강덕희; 최규복; 김승정; 류동열 | Article |
2013 | The role of uric acid in the pathogenesis of human cardiovascular disease | 강덕희 | Review |
2004 | Transplant graft vasculopathy: An emerging target for prevention and treatment of renal allograft dysfunction | 강덕희 | Review |
2003 | Tubulointerstitial disease: Role of ischemia and microvascular disease | 강덕희 | Review |
2006 | Unearthing uric acid: An ancient factor with recently found significance in renal and cardiovascular disease | 강덕희 | Short Survey |
2011 | Uric Acid and Chronic Kidney Disease: New Understanding of an Old Problem | 강덕희 | Article |
2013 | Uric acid and chronic kidney disease: Which is chasing which? | 강덕희 | Review |
2005 | Uric acid and chronic renal disease: Possible implication of hyperuricemia on progression of renal disease | 강덕희 | Review |
2005 | Uric acid and preeclampsia | 강덕희 | Review |
2014 | Uric acid and the kidney | 강덕희 | Book Chapter |
2005 | Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease | 강덕희 | Review |
2013 | Uric acid attenuates nitric oxide production by decreasing the interaction between endothelial nitric oxide synthase and calmodulin in human umbilical vein endothelial cells: A mechanism for uric acid-induced cardiovascular disease development | 강덕희; 조인호; 박정현 | Article |
2005 | Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter | 강덕희 | Article |